Molina Healthcare stock falls as first-half EPS covers 73.5% of 2026 floor

Molina Healthcare, Inc. shares sank 9.4% to $200.85 after hours Wednesday. The 18:09 EDT quote was preliminary. Investors looked past an earnings beat and higher guidance.

NEW YORK, July 22, 2026, 18:12 EDT

Molina Healthcare, Inc. shares sank 9.4% to $200.85 after hours Wednesday. The 18:09 EDT quote was preliminary. Investors looked past an earnings beat and higher guidance.

The key was the guidance bridge. Molina earned $3.86 in adjusted EPS during the first half. Its new $5.25 floor leaves a $1.39 gap.

That means 73.5% of the floor is already booked. The company can still finish above guidance. The remaining hurdle equals 26.5%.

The quarter cleared consensus. Medical costs consumed more premium revenue.

MeasureReported figureComparatorDifference
Q2 adjusted EPS$1.51$1.39 pre-report estimate8.6% above
Q2 total revenue$10.874 billion$10.83 billion pre-report estimate0.4% above
Medical care ratio92.2%90.4% a year earlier180 basis points higher
First-half adjusted EPS$3.86$5.25 full-year floor73.5% booked
Second-half gap to floor$1.39$3.86 earned in first half64.0% smaller

The estimates were pre-report consensus figures. Percentages and the $1.39 gap are calculations from reported data.

Year-on-year figures were much weaker. Premium revenue fell 6% as membership declined. Adjusted EPS dropped from $5.48 to $1.51.

Molina said the 25-cent guidance increase reflected first-half Medicaid results. Medicare’s outlook improved by $1.50 a share. Marketplace fell by the same amount. Those revisions netted to zero.

“The imbalance between Medicaid rates and medical cost trend appears to have stabilized,” Chief Executive Joseph Zubretsky said. He expects future rate increases to correct the gap. Molina still calls 2026 the trough for Medicaid pretax margins. Stock Titan

Cost pressure still clouded the result. Consolidated MCR rose to 92.2% from 90.4%. Marketplace MCR reached 88.9%, above Molina’s expectations. It cited unfavorable acuity and risk-adjustment effects.

Peers set a demanding benchmark. UnitedHealth Group Incorporated cut its medical cost ratio 270 basis points to 86.7% last week. Its shares gained nearly 8%. Elevance Health, Inc. reported an 80-basis-point rise in its benefit expense ratio, to 89.7%. Business mixes differ.

U.S. cash markets were closed at the dateline. Molina ended Wednesday down 2.1% at $221.74. That close was 1.4% below July 16. It sat 9.5% under the July 14 high.

The stock joined the S&P MidCap 400 before Wednesday’s open. Tuesday volume reached 9.7 million shares, nearly ten times its 50-day average.

In the week ahead, Molina’s call starts Thursday at 8:00 a.m. EDT. Management will face questions on Marketplace acuity, state rate timing and Florida start-up costs. Centene Corporation reports July 28, offering the next Medicaid-heavy peer check.

Risks cut both ways. Faster rate updates or softer utilization could lift earnings above the floor. Worse Marketplace acuity, delayed rates or Florida losses above guidance could reduce it.

For now, Molina has booked most of its stated floor. The stock reaction shows investors want proof that margins are turning.

Michał Rogucki

Michał Rogucki is a senior markets reporter at TS2.tech. His coverage ranges from stocks and technology to economic developments affecting global markets. He graduated from Humboldt University of Berlin and worked in investment research and market analysis before becoming a financial journalist.

Capital One (NYSE:COF) challenge may postpone as much as $110 million in projected quarterly interest expenses
Previous Story

Capital One (NYSE:COF) challenge may postpone as much as $110 million in projected quarterly interest expenses

Meta Platforms (NASDAQ:META) set for almost twofold surge in quarterly capital expenditure rate
Next Story

Meta Platforms (NASDAQ:META) set for almost twofold surge in quarterly capital expenditure rate